Search research articles
Contact Us
Filters
Showing results (51-60 of 101) with videos related to
Page
of 11
Sort By:
Leukemia & Lymphoma
|
June 22, 2013
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
Kristen Ganjoo, Fangxin Hong, Sandra J Horning, et al.
Breast Cancer Research and Treatment
|
October 16, 2019
The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study
Donna L Berry, Traci M Blonquist, Barbara Halpenny, et al.
Psycho-Oncology
|
January 24, 2019
The effect of a lifestyle risk reduction intervention on lifestyle adherence and health-related quality of life in nonsmall cell lung cancer survivors: Feasibility study outcomes
Mary E Cooley, Traci M Blonquist, Fangxin Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499
Mitchell R Smith, Hailun Li, Leo Gordon, et al.
Gynecologic Oncology
|
September 3, 2022
How does patient-centered communication in ovarian cancer care enhance patient well-being? A mixed methods study
Rachel A Pozzar, Niya Xiong, Fangxin Hong, et al.
British Journal of Haematology
|
April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Blood Cancer Journal
|
March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
Rebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Gynecologic Oncology
|
August 29, 2021
Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancer
Rachel A Pozzar, Niya Xiong, Fangxin Hong, et al.
BMC Cancer
|
July 13, 2014
The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial
Donna L Berry, Fangxin Hong, Barbara Halpenny, et al.
Urology Practice
|
August 5, 2021
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support
Donna L Berry, Fangxin Hong, Barbara Halpenny, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 101) with videos related to
Sort By:
Page
of 11
Leukemia & Lymphoma
|
June 22, 2013
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
Kristen Ganjoo, Fangxin Hong, Sandra J Horning, et al.
Breast Cancer Research and Treatment
|
October 16, 2019
The Jacki Jacket after mastectomy with reconstruction: a randomized pilot study
Donna L Berry, Traci M Blonquist, Barbara Halpenny, et al.
Psycho-Oncology
|
January 24, 2019
The effect of a lifestyle risk reduction intervention on lifestyle adherence and health-related quality of life in nonsmall cell lung cancer survivors: Feasibility study outcomes
Mary E Cooley, Traci M Blonquist, Fangxin Hong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499
Mitchell R Smith, Hailun Li, Leo Gordon, et al.
Gynecologic Oncology
|
September 3, 2022
How does patient-centered communication in ovarian cancer care enhance patient well-being? A mixed methods study
Rachel A Pozzar, Niya Xiong, Fangxin Hong, et al.
British Journal of Haematology
|
April 1, 2015
Response-adapted therapy for aggressive non-Hodgkin's lymphomas based on early [18F] FDG-PET scanning: ECOG-ACRIN Cancer Research Group study (E3404)
Lode J Swinnen, Hailun Li, Andrew Quon, et al.
Blood Cancer Journal
|
March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine era
Rebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Gynecologic Oncology
|
August 29, 2021
Perceived patient-centered communication, quality of life, and symptom burden in individuals with ovarian cancer
Rachel A Pozzar, Niya Xiong, Fangxin Hong, et al.
BMC Cancer
|
July 13, 2014
The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial
Donna L Berry, Fangxin Hong, Barbara Halpenny, et al.
Urology Practice
|
August 5, 2021
Evaluating Clinical Implementation Approaches for Prostate Cancer Decision Support
Donna L Berry, Fangxin Hong, Barbara Halpenny, et al.
Page
of 11